AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10208997
Drug: abciximab with
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: abciximab with low-dose heparin (70 U/kg initial bolus)
Trial: 10208997
Drug: abciximab with
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: abciximab with standard-dose heparin (100 U/kg initial bolus)
Trial: 10208997
Drug: placebo with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo with standard-dose heparin (100 U/kg initial bolus)
Trial: 10208997
Drug: abciximab therapy
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: abciximab therapy
Trial: 7790694
Drug: High Protein
RxNorm normalized name: Vital High Protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High Protein diet (HP) at 1.5 g/kg body weight/day
Trial: 7790694
Drug: Marginal Protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marginal Protein diet (MP) at 1.0 g/kg body weight/day
Trial: 31142441
Drug: Empagliflozin (EMPA)
RxNorm normalized name: Empagliflozin
DrugBank: Empagliflozin (DB09038)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Empagliflozin (EMPA) 10 mg
Trial: 31142441
Drug: Empagliflozin (EMPA)
RxNorm normalized name: Empagliflozin
DrugBank: Empagliflozin (DB09038)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Empagliflozin (EMPA) 25 mg
Trial: 28196207
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate 400 mg once daily (400 mg/d)
Trial: 28196207
Drug: Imatinib mesylate
RxNorm normalized name: Imatinib Mesylate
DrugBank: Imatinib (DB00619)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Imatinib mesylate 800 mg twice daily (800 mg/d)
Trial: 28196207
Drug: Imatinib as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib as sole therapy
Trial: 28196207
Drug: Additional systemic
RxNorm normalized name: chromous chloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Additional systemic agents
Trial: 23340492
Drug: Dietary intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dietary intervention (daily supplementation with 1200 mg n-3 LCPUFAs and dietary counseling to reduce arachidonic acid (AA) intake)
Trial: 15245938
Drug: Concurrent gemcitabine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent gemcitabine (initial dose 10 mg/m2, increased as tolerated) and radiotherapy (RT)
Trial: 15245938
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of gemcitabine (greater than 20 mg/m2)
Trial: 15245938
Drug: Patients who
RxNorm normalized name: MAYZENT 0.25mg Tablet Starter Pack (For Patients Who Will Receive The 2mg Maintenance Dosage)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients who experienced dose-limiting toxicity (DLT)
Trial: 11403535
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors (PPIs) for long-term management of H. pylori-negative ulcers
Trial: 9678430
Drug: Intravenous iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous iron gluconate
Trial: 9678430
Drug: Oral ferrous
RxNorm normalized name: ferrous fumarate Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ferrous iron
Trial: 8048390
Drug: Chemotherapy (CT)
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (CT) plus Radiotherapy (RT)
Trial: 2659312
Drug: High energy
RxNorm normalized name: High energy formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High energy food supplement of 3.31 MJ for the first 3 months of the 6-month intervention period.
Trial: 18201641
Drug: Behavioral Internet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral Internet Treatment (BIT)
Trial: 11199864
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg ISDN
Trial: 3536397
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg ISDN
Trial: 11199864
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg SR ISDN
Trial: 11199864
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg SR ISDN
Trial: 11199864
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg SR ISDN (3x dosing)
Trial: 30854986
Drug: 2.7 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.7 g/d of DHA
Trial: 30854986
Drug: 2.7 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.7 g/d of EPA
Trial: 30854986
Drug: 3 g/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 g/d of maize oil
Trial: 27593504
Drug: Fluticasone furoate
RxNorm normalized name: Fluticasone Furoate
DrugBank: Fluticasone furoate (DB08906)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fluticasone furoate (100 μg) and vilanterol (25 μg) once daily
Trial: 22231020
Drug: High concentrate
RxNorm normalized name: A Mulsin High Concentrate 300,000unit Emulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High concentrate (450 g/day)
Trial: 22231020
Drug: Moderate concentrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate concentrate (300 g/day)
Trial: 22231020
Drug: Low concentrate
RxNorm normalized name: NIACINAMIDE 2 g in 100 mL / ADENOSINE 0.04 g in 100 mL TOPICAL LIQUID [Hydrating all in one glow concentrate ampoule]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low concentrate (150 g/day)
Trial: 20102936
Drug: Atorvastatin 80
RxNorm normalized name: atorvastatin 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 80 mg/day for 48 hours before and 48 hours after contrast medium administration
Trial: 18854539
Drug: High-dose B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose B vitamin supplementation (5 mg/d of folate, 25 mg/d of vitamin B(6), 1 mg/d of vitamin B(12))
Trial: 15892275
Drug: Shenmai Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shenmai Injection (SMI) plus conventional western medicine
Trial: 12592681
Drug: Conventional western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional western medicine (Control)
Trial: 10404806
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) replacement therapy, initial dose of 1-3 IU/m2 x day (9-27 microg/kg), tapered to 1.30+/−0.38 IU/m2 x day (11 g/kg)
Trial: 7570327
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment regimens
Trial: 2202385
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment with levodopa/carbidopa (Sinemet Plus)
Trial: 6375890
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment and placebo
Trial: 7196705
Drug: Hydroxyzine 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyzine 100 mg IV
Trial: 22456951
Drug: DEN (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DEN (200 mg/kg body weight) followed by 2-acetylamino fluorine (150 mg/kg body weight)
Trial: 21342217
Drug: Atazanavir/ritonavir (ATV/RTV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atazanavir/ritonavir (ATV/RTV) 300/100 mg every 24 h for 14 days
Trial: 21342217
Drug: Atazanavir (ATV)
DrugBank: Atazanavir (DB01072)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Atazanavir (ATV) 400 mg every 24 h for 14 days
Trial: 11113837
Drug: Biofeedback therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback therapy (BF) alone
Trial: 11113837
Drug: Biofeedback therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Biofeedback therapy (BF) + oral laxatives (LAX)
Trial: 8421417
Drug: Amoxicillin (three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin (three times a day)
Trial: 26871692
Drug: Combined group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined group (electrical stimulation plus laser therapy)
Trial: 26871692
Drug: Laser group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laser group (dose 4-6 J per point, 6 points at the knee joint)
Trial: 24755192
Drug: m-TOR therapy
RxNorm normalized name: m-phenylenediamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-TOR therapy (SRL and EVL)
Trial: 24755192
Drug: m-TOR therapy
RxNorm normalized name: m-phenylenediamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: m-TOR therapy
Trial: 21302489
Drug: Shaogen Decoction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Shaogen Decoction (SGD) administered 10 mL, thrice a day, increased to every 2 hours if 2nd or over 2nd grade ARE occurred.
Trial: 21302489
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated with antibiotics (cefuroxime 4.5 g) and hormone (dexamethasone 5 mg) by intravenous infusion for 7 days.
Trial: 18394624
Drug: Lanolin eye
RxNorm normalized name: Lanolin
DrugBank: Lanolin (DB11112)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lanolin eye ointment (Duratears)
Trial: 11550964
Drug: Leflunomide 20
RxNorm normalized name: leflunomide 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leflunomide 20 mg/day
Trial: 9663720
Drug: Budesonide 9
RxNorm normalized name: budesonide 9 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 9 mg for 10 weeks
Trial: 9663720
Drug: Methylprednisolone 32
RxNorm normalized name: methylprednisolone 32 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 32 mg for 3 weeks with tapering
Trial: 18048820
Drug: Oral minocycline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral minocycline
Trial: 3065267
Drug: Topical tetracycline
RxNorm normalized name: TETRACYCLINE HYDROCHLORIDE 30 mg in 1 mL TOPICAL SPRAY [Tetracyte Topical Tetracycline Hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical tetracycline ointment
Trial: 28512843
Drug: New brightening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New brightening complex cream containing niacinamide, tranexamic acid, oxyresveratrol, glutathione disulfide, and linoleic acid applied on the face two times per day for 12 weeks
Trial: 28512843
Drug: New brightening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New brightening complex cream
Trial: 26387055
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (400 mcg)
Trial: 26387055
Drug: Intra-arterial nitroglycerin
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial nitroglycerin (200 mcg)
Trial: 26387055
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (400 mcg) in patients < 1.65 m height
Trial: 26387055
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (400 mcg) in patients with diabetes
Trial: 26387055
Drug: Sublingual nitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual nitroglycerin (400 mcg) in smokers
Trial: 23107873
Drug: S18886 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S18886 30 mg/d for 5 days
Trial: 21959813
Drug: Morphine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (2 or 4 mg)
Trial: 21959813
Drug: Pethidine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pethidine (25 or 50 mg)
Trial: 21959813
Drug: Fentanyl (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (50 μg)
Trial: 21959813
Drug: All opioids
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All opioids (morphine, pethidine, fentanyl)
Trial: 18294482
Drug: Dalteparin 120
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dalteparin 120 IU/kg s.c. (maximum 10,000 IU) twice daily for 5 to 7 days in hospital, followed by placebo for 3 months (n = 285)
Trial: 18294482
Drug: Sex- and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex- and weight-adjusted doses of dalteparin (5000 or 7500 IU) twice daily for 3 months (n = 270)
Trial: 10624992
Drug: Ropivacaine 0.5%
RxNorm normalized name: ROPivacaine 0.5% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 0.5% (20 mL)
Trial: 10624992
Drug: Bupivacaine 0.5%
RxNorm normalized name: BUPivacaine 0.5% injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.5% (20 mL)
Trial: 31736123
Drug: Single Ablative
RxNorm normalized name: ABL
DrugBank: Lauric acid (DB03017)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single Ablative Fractional Resurfacing Laser Treatment (FLR)
Trial: 29033355
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia tramadol + SAPB (Group S)
Trial: 29033355
Drug: Intravenous patient-controlled
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous patient-controlled analgesia tramadol (Group T)
Trial: 27067393
Drug: Topical diclofenac
RxNorm normalized name: diclofenac Topical Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical diclofenac 3% gel
Trial: 27067393
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (diclofenac and calcitriol)
Trial: 27067393
Drug: Topical calcitriol
RxNorm normalized name: calcitriol Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical calcitriol 3 μg/g ointment
Trial: 22652344
Drug: ALVAC-HIV (vCP1521)
RxNorm normalized name: HIV Integrase Inhibitor
DrugBank: HIV Integrase Inhibitor (DB16114)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALVAC-HIV (vCP1521) and AIDSVAX B/E vaccine regimen
Trial: 18783504
Drug: bupropion sustained-release
RxNorm normalized name: bupropion
DrugBank: Bupropion (DB01156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: bupropion sustained-release (SR) treatment
Trial: 17057382
Drug: placebo pill
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: placebo pill
Trial: 15629356
Drug: DTPa-IPV/Hib and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DTPa-IPV/Hib and HBV vaccines administered separately
Trial: 31814044
Drug: Magnesium supplementation
RxNorm normalized name: Magnesium
DrugBank: Magnesium (DB14513)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium supplementation (intravenous magnesium sulfate to maintain serum magnesium level around 3 mg/dL for 3 days)
Trial: 29702040
Drug: Combination diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination diet (whole grains and fruits and vegetables)
Trial: 27104803
Drug: Continuation cognitive
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuation cognitive therapy (C-CT)
Trial: 27104803
Drug: Pill placebo
RxNorm normalized name: placebo Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pill placebo (PBO) plus clinical management
Trial: 22134624
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg minodronate once a day
Trial: 17205494
Drug: Multilayer compression
RxNorm normalized name: zileuton
DrugBank: Zileuton (DB00744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multilayer compression treatment with ULSA score of 50 or less
Trial: 17205494
Drug: Multilayer compression
RxNorm normalized name: zileuton
DrugBank: Zileuton (DB00744)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multilayer compression treatment with ULSA score of greater than 50
Trial: 11193270
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (Epidural bupivacaine and Intravenous morphine)
Trial: 1606457
Drug: Anticoagulant agents
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anticoagulant agents
Trial: 31590926
Drug: Pharmacist-led care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pharmacist-led care coordination during transition from inpatient to community setting with follow-up medication therapy management (MTM) by community pharmacists.
Trial: 31590926
Drug: Medication therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication therapy management (MTM) provided by community pharmacists postdischarge.
Trial: 28850471
Drug: 2mg morphine
RxNorm normalized name: morphine sulfate 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2mg morphine into inflamed tissue
Trial: 28850471
Drug: 2mg morphine
RxNorm normalized name: morphine sulfate 2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2mg morphine into non-inflamed tissue
Trial: 28850471
Drug: Time to
RxNorm normalized name: Overtime Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time to first analgesic intake
Trial: 20427088
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg ranibizumab + prompt laser
Trial: 20427088
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg ranibizumab + deferred laser
Trial: 20427088
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg triamcinolone + prompt laser
Trial: 20427088
Drug: sham injection
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sham injection + prompt laser
Trial: 26248590
Drug: Insulin pump
RxNorm normalized name: insulin pump syringe
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin pump therapy (CSII)
Trial: 18227475
Drug: Long-acting insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Long-acting insulin analogs (glargine and detemir)
Trial: 10560985
Drug: Crinone vaginal
RxNorm normalized name: Crinone Vaginal Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crinone vaginal progesterone gel (90 mg once daily)
Trial: 8904262
Drug: Inhalation anesthesia
RxNorm normalized name: Gelato Anesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anesthesia with nitrous oxide and isoflurane
Trial: 31689480
Drug: Chinese herbal
RxNorm normalized name: GINGER 28 mg in 100 mL TOPICAL OIL [Pain Relief Honzo Seika Chinese Herbal Aroma Oil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese herbal medicines (Fufang Chuanxiong Capsule and Xinyue Capsule)
Trial: 31689480
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine standard therapy
Trial: 24565955
Drug: Atrasentan (bone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atrasentan (bone targeted endothelin-A receptor antagonist)
Trial: 22316089
Drug: LGS-Off (continued
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LGS-Off (continued insulin delivery regardless of SG value)
Trial: 10521964
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg every 3 hours
Trial: 10521964
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg every 6 hours
Trial: 10521964
Drug: Omeprazole 80
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80 mg every 12 hours
Trial: 1685793
Drug: Suriclone (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suriclone (0.1 mg tid)
Trial: 1685793
Drug: Suriclone (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suriclone (0.2 mg tid)
Trial: 1685793
Drug: Suriclone (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suriclone (0.3 mg tid)
Trial: 1685793
Drug: Suriclone (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suriclone (0.4 mg tid)
Trial: 1685793
Drug: Diazepam (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam (5 mg tid)
Trial: 29847468
Drug: Ketamine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (1 to 2 mg/kg)
Trial: 29847468
Drug: Methohexital (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methohexital (1 to 2 mg/kg)
Trial: 31687205
Drug: Nebivolol (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebivolol (5 mg/day)
Trial: 1729814
Drug: Metoprolol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (50 mg/day)
Trial: 14700340
Drug: 25% EDTA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% EDTA gel applied for 15 seconds
Trial: 14700340
Drug: 25% EDTA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% EDTA gel applied for 1 minute
Trial: 14700340
Drug: 25% EDTA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25% EDTA gel applied for 3 minutes
Trial: 10965426
Drug: Topical dexpanthenol
RxNorm normalized name: dexpanthenol Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical dexpanthenol